Propranolol, a beta-blocker typically prescribed to handle irregular coronary heart charges and different situations, has predominant anti-most cancers properties, insist researchers in a model recent medical glimpse printed in ecancermedicalscience.
The Repurposing Medication in Oncology (ReDO) venture, a world collaboration between the Anticancer Fund, Belgium, and US primarily based fully GlobalCures, says that current and broadly-used non-most cancers remedy may effectively additionally signify a somewhat untapped supply of recent therapies for many cancers.
Historically, pharmaceutical corporations commit minute time to “repurposing” current remedy. The ReDO venture hopes to interchange that, elevating consciousness by publishing a series of articles in ecancer to half proof for the expend of those therapies in most cancers remedy.
